PERTH, W. AUSTRALIA — MedTech pioneer Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) has announced the official product launch of its world leading predictive diagnostic test for diabetic kidney disease, “PromarkerD”.
The pioneering diagnostic test was launched by Proteomics International partner Omics Global Solutions (Puerto Rico, USA) through its distributor in the Dominican Republic, Macrotech Farmaceutica, the exclusive provider of dialysis services in the country.
Article: PromarkerD Diagnostic Test Leader Officially Launched